| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | HSPA9 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | EMC7 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | DBNL | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | DNAJC18 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MBP | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | LAMA1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | TYRO3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | SCRT1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | RP11-444E17.6 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
